Robert Amato, DO
The University of Texas Health Science Center, Houston
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert Amato, DO as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02560012 · Personalized Targeted Inhibitors Treatment in Renal Cell CancerThe University of Texas Health Science Center, Houston · terminated · Carcinoma, Renal Cell · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 118 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A Shared MicroCT Instrument for Virtual Histology Imaging of Bone and Soft TissueS10RR025687 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2010 · $359,080 awarded in 2010Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.